BioSpace News Archive

As previously announced, Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga”) and Aegea Biotechnologies, Inc. (“Aegea”) have entered into a collaboration agreement to develop COVID-19 (Novel Coronavirus) assays. Aegea has now informed Tauriga Sciences that in addition to the high sensitivity, high specificity COVID-19 assay under development (the “SARS-CoV-2 Test”), Aegea is undertaking to use another of its pate

Check-Cap Ltd. announced that it has entered into definitive agreements with several institutional and accredited investors for the purchase and sale of 6,666,669 of the Company’s ordinary shares, at a purchase price of $0.60 per share, in a registered direct offering.

Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB:ASPCF) (“Acerus” or the “Company”) today announced that it has received a Notice of Deficiency (“NOD”) for its avanafil New Drug Submission (NDS). Health Canada has requested the provision of additional quality information related to the avanafil drug substance in alignment with Intern

- Ongoing Phase 1 dose escalation and expansion study with CUE-101 as a monotherapy in post first-line recurrent/metastatic HNSCC patients to be amended to include combination of CUE-101 with standard of care KEYTRUDA as first-line therapy - Preliminary data from early patient cohorts in the current ongoing CUE-101 monotherapy Phase 1 trial in post first-line recurrent/metastatic HNSCC patients demonstrates tolerability and drug exposure, and provides confidence for drug activity consist

Cocrystal Pharma, Inc . (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral therapeutics, announced today the appointment of Dr. Roger Kornberg to its Board of Directors

Highlights: Dramatic reduction in viral load in the lungs of mice treated with RECCE ® 327 as compared to the approved antiviral drug treated and vehicle control untreated groups RECCE ® 327’s unique mechanism of action reinforces efficacy against both bacterial cells and enveloped viruses SYDNEY, Australia, April 20, 2020 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd ( ASX: RCE ), the company developing a new class of broad-spectrum synthetic antibiotics, today announced posit

Mint Pharmaceuticals, one of Canada’s leading generic pharmaceutical companies, is donating Hydroxychloroquine to support a critical and timely St. Joseph’s Healthcare Hamilton study being led at this site by Dr. Zain Chagla, Associate Professor of Medicine at McMaster University . The randomized placebo-controlled study, conducted

ImpediMed Limited, a medical software technology company that non-invasively measures, monitors and manages fluid status and tissue composition using bioimpedance spectroscopy (BIS), today announced the release of its most comprehensive software package to date for the SOZO® digital health platform.

As previously announced, in light of public health concerns regarding the coronavirus or COVID-19, Select Medical Holdings Corporation (the “Company”) (NYSE: SEM), will hold its 2020 Annual Meeting of Stockholders (the “Annual Meeting”) in virtual meeting format only.

Biocept, Inc . (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces the availability of research-use-only (RUO) kits that can allow molecular laboratories around the world to util